New York, New York-- (Newsfile Corp. - November 15, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation ...

The "Mitral Valve Annuloplasty Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" report has been added to ...

New York, New York-- (Newsfile Corp. - November 14, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation ...

Replacing a shower valve is a DIY project most homeowners can do, but if leaks or issues persist, you should call a ...

Cardiologist Dr. Josiah Brown, specializing in minimally invasive therapies, is the newest team member at Alaska Heart & ...

Edwards Lifesciences Investors are Notified to Contact BFA Law before Expiration of December 13 Class Action Deadline ...

Innoventric's Trillium, now in clinical trials, is implanted in a 10-minute procedure under sedation to treat a leak in the ...

Elevating DSH2’s heart and lung medical hub to the forefront of healthcare by offering minimally invasive cardiac surgery ...

A Charleston woman was always short of breath and suffered from an undertreated heart problem. A new device at MUSC has her ...

EW INVESTOR UPDATE: Did Edwards Lifesciences Mislead Investors Causing Losses? Contact BFA Law About The Pending Securities Fraud Lawsuit (NYSE:EW) ...

The global prosthetic heart valve market is projected to be valued at USD 13,234.9 million by 2023 and is expected to grow ...

Edwards categorizes its therapies and technologies into four categories: Transcatheter Aortic Valve Replacement (“TAVR”), Transcatheter Mitral and Tricuspid Therapies (“TMTT”), Surgical Structural ...